The use of 17 alpha-hydroxyprogesterone caproate (17P) in women with cervical cerclage

American Journal of Perinatology

Volumn 25, Issue 5, 2008, Pages 271-276

  Rebarber, Andrei ^a,b   Cleary Goldman, Jane ^a   Istwan, Niki B ^b   Rhea, Debbie J ^b   Desch, Cheryl ^b   Russo Stieglitz, Karen ^c   Saltzman, Daniel H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b Matria Healthcare ^*  (United States)

^c Valley Health System   (United States)

Author keywords

17 hydroxyprogesterone caproate; Cervical cerclage; Recurrent spontaneous preterm delivery

Indexed keywords

HYDROXYPROGESTERONE CAPROATE;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ELECTRONICS; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; NURSING CARE; OUTCOME ASSESSMENT; PATIENT MONITORING; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; UTERINE CERVIX CERCLAGE; UTERUS CONTRACTION;

ADULT; CERCLAGE, CERVICAL; COHORT STUDIES; ESTRADIOL ANTAGONISTS; FEMALE; GESTATIONAL AGE; HUMANS; HYDROXYPROGESTERONES; NURSING CARE; OBSTETRIC LABOR, PREMATURE; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES;

EID: 44849087086     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1064935     Document Type: Article

References (9)

1. Martin JA, Hamilton BE, Sutton PD, et al. Births: Final Data for 2004. National Vital Statistics Reports. Hyattsville, MD: National Center for Health Statistics; 2006
2. Iams JD. Abnormal cervical competence. In: Creasy RK and Resnick R, eds. Maternal Fetal Medicine Principles and Practice. 5th ed. Philadelphia: WB Saunders; 2004:603-622
3. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin. Cervical insufficiency. Obstet Gynecol 2003;102:1091-1099
4. Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for short cervix on ultrasonography: meta-analysis of trials using individual patient-level data. Obstet Gynecol 2005;106:181-189
5. Meis PJ, Klebanoff M, Thorn E, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003;348:2379-2385
6. American College of Obstetricians and Gynecologists. ACOG Committee Opinion. Use of progesterone to reduce preterm birth. Obstet Gynecol 2003;102:1115-1116
7. Gonzalez-Quintero VH, Istwan NB, Rhea DJ, Smarkusky L, Hoffman MC, Stanziano GJ. Gestational age at initiation of 17a-hydroxyprogesterone caproate (17P) and recurrent preterm delivery. J Matern Fetal Neonatal Med 2007;20:249-252
8. How HY, Barton JR, Istwan NB, Rhea DJ, Stanziano GJ. Prophylaxis with 17 alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery: does gestational age at initiation of treatment matter? Am J Obstet Gynecol 2007;197:260. e1-e4
9. Facchinetti F, Paganelli S, Comitini G, Dante G, Volpe A. Cervical length changes during preterm cervical ripening: effects of 17-α- hydroxyprogesterone caproate. Am J Obstet Gynecol 2007;196(5):453. e1-e4